デフォルト表紙
市場調査レポート
商品コード
1087250

前立腺癌治療薬の世界市場:産業分析、動向、市場規模、予測(~2028年)

Prostate Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

出版日: | 発行: Infinium Global Research (IGR) | ページ情報: 英文 100 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
前立腺癌治療薬の世界市場:産業分析、動向、市場規模、予測(~2028年)
出版日: 2022年05月25日
発行: Infinium Global Research (IGR)
ページ情報: 英文 100 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の前立腺癌治療薬の市場規模は、2022~2028年の予測期間において8.5%のCAGRで成長すると予測されています。

当レポートでは、世界の前立腺癌治療薬市場について調査分析し、市場の促進要因、抑制要因、市場機会、マクロ指標分析、コンポーネント・流通チャネル・地域別市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 調査方法
  • 調査アプローチ

第2章 エグゼクティブサマリー

  • 前立腺癌治療薬市場のハイライト
  • 前立腺癌治療薬市場の予測
  • 前立腺癌治療薬市場の地域のハイライト

第3章 世界の前立腺癌治療薬:市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 前立腺癌治療薬市場に対するCOVID-19の影響分析
  • ポーターのファイブフォース分析
  • IGR-成長マトリックス分析
    • IGR-成長マトリックス分析:コンポーネント別
    • IGR-成長マトリックス分析:流通チャネル別
    • IGR-成長マトリックス分析:地域別
  • 前立腺癌治療薬市場のバリューチェーン分析

第4章 前立腺癌治療薬市場のマクロ指標分析

第5章 世界の前立腺癌治療薬市場:コンポーネント別

  • ホルモン療法
    • LHRH(黄体形成ホルモン放出ホルモン)拮抗薬
    • LHRH(黄体形成ホルモン放出ホルモン)アゴニスト
    • 抗アンドロゲン剤
  • 化学療法
  • 免疫療法
  • 放射線治療

第6章 世界の前立腺癌治療薬市場:流通チャネル別

  • 病院薬局
  • 小売薬局
  • 販売・糖尿病関連

第7章 世界の前立腺癌治療薬市場:地域別(2022~2028年)

  • 北米
    • コンポーネント別
    • 流通チャネル別
    • 国別
  • 欧州
    • コンポーネント別
    • 流通チャネル別
    • 国別
  • アジア太平洋
    • コンポーネント別
    • 流通チャネル別
    • 国別
  • その他の地域
    • コンポーネント別
    • 流通チャネル別
    • サブ地域別

第8章 企業プロファイルと競合情勢

  • 競合情勢
  • 企業プロファイル
    • Pfizer Inc.
    • Abbott Laboratories
    • AstraZeneca plc
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb
    • Johnson & Johnson
    • Sanofi
    • AbbVie, Inc.
    • Teva Pharmaceuticals
    • Takeda Pharmaceuticals
目次
Product Code: HC0094

The report on the global prostate cancer therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global prostate cancer therapeutics market to grow with a CAGR of 8.5% over the forecast period from 2022-2028. The study on prostate cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on prostate cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global prostate cancer therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global prostate cancer therapeutics market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Prevalence of prostate cancer
  • Innovations in the development of new drugs and therapies of cancer

2) Restraints

  • High cost of prostate cancer drugs

3) Opportunities

  • Rising investment in R&D of new drugs

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global prostate cancer therapeutics market is segmented on the basis of component, and distribution channel.

The Global Prostate Cancer Therapeutics Market by Component

  • Hormonal Therapy

LHRH (Luteinizing Hormone Releasing Hormone) Antagonists

LHRH (Luteinizing Hormone Releasing Hormone) Agonists

Anti-androgen

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy

The Global Prostate Cancer Therapeutics Market by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Sales and Diabetes

Company Profiles

The companies covered in the report include

  • Pfizer Inc.
  • Abbott Laboratories
  • AstraZeneca plc
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Sanofi
  • AbbVie, Inc.
  • Teva Pharmaceuticals
  • Takeda Pharmaceuticals

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the prostate cancer therapeutics market.

2. Complete coverage of all the segments in the prostate cancer therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global prostate cancer therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Prostate Cancer Therapeutics Market Highlights
  • 2.2. Prostate Cancer Therapeutics Market Projection
  • 2.3. Prostate Cancer Therapeutics Market Regional Highlights

3. Global Prostate Cancer Therapeutics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Prostate Cancer Therapeutics Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Component
    • 3.5.2. IGR-Growth Matrix Analysis by Distribution Channel
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Prostate Cancer Therapeutics Market

4. Prostate Cancer Therapeutics Market Macro Indicator Analysis

5. Global Prostate Cancer Therapeutics Market by Component

  • 5.1. Hormonal Therapy
    • 5.1.1. LHRH (Luteinizing Hormone Releasing Hormone) Antagonists
    • 5.1.2. LHRH (Luteinizing Hormone Releasing Hormone) Agonists
    • 5.1.3. Anti-androgen
  • 5.2. Chemotherapy
  • 5.3. Immunotherapy
  • 5.4. Radiation Therapy

6. Global Prostate Cancer Therapeutics Market by Distribution Channel

  • 6.1. Hospital Pharmacy
  • 6.2. Retail Pharmacy
  • 6.3. Sales and Diabetes

7. Global Prostate Cancer Therapeutics Market by Region 2022-2028

  • 7.1. North America
    • 7.1.1. North America Prostate Cancer Therapeutics Market by Component
    • 7.1.2. North America Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.1.3. North America Prostate Cancer Therapeutics Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Prostate Cancer Therapeutics Market by Component
    • 7.2.2. Europe Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.2.3. Europe Prostate Cancer Therapeutics Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Prostate Cancer Therapeutics Market by Component
    • 7.3.2. Asia-Pacific Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.3.3. Asia-Pacific Prostate Cancer Therapeutics Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Prostate Cancer Therapeutics Market by Component
    • 7.4.2. RoW Prostate Cancer Therapeutics Market by Distribution Channel
    • 7.4.3. RoW Prostate Cancer Therapeutics Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Prostate Cancer Therapeutics Market
  • 8.2. Companies Profiles
    • 8.2.1. Pfizer Inc.
    • 8.2.2. Abbott Laboratories
    • 8.2.3. AstraZeneca plc
    • 8.2.4. Astellas Pharma Inc.
    • 8.2.5. Bristol-Myers Squibb
    • 8.2.6. Johnson & Johnson
    • 8.2.7. Sanofi
    • 8.2.8. AbbVie, Inc.
    • 8.2.9. Teva Pharmaceuticals
    • 8.2.10. Takeda Pharmaceuticals